Zonisamide-induced weight loss in schizophrenia: Case series

Jaewon Yang, Moon Soo Lee, Sook Haeng Joe, In Kwa Jung, Seung Hyun Kim

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)


Weight gain and metabolic disturbances constitute bothersome problems in schizophrenic patients treated with atypical antipsychotics. Several medications, exercise regimens, and lifestyle changes have been used in attempts to ameliorate these problems. We describe 3 patients with schizophrenia who manifested distinct weight loss and reduction in waist circumference during medication with zonisamide. This report suggests that zonisamide might be associated with weight loss in patients with schizophrenia.

Original languageEnglish
Pages (from-to)104-106
Number of pages3
JournalClinical Neuropharmacology
Issue number2
Publication statusPublished - 2010 Mar


  • Obesity
  • Schizophrenia
  • Waist circumference
  • Weight loss
  • Zonisamide

ASJC Scopus subject areas

  • Pharmacology
  • Clinical Neurology
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Zonisamide-induced weight loss in schizophrenia: Case series'. Together they form a unique fingerprint.

Cite this